Back to Search
LAWRENCE ADLER, M.D.
M.D.
Family Medicine Physician
NPI: 1609898469IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
230633(NY)
CMS Specialties
PrimaryFAMILY PRACTICE
Education
OTHER
Class of 1997
Research & Publications (20)
Once-daily atomoxetine for adult attention-deficit/hyperactivity disorder: a 6-month, double-blind trial.
PMID 19142107·J Clin Psychopharmacol·2009
4-observational
Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study.
PMID 19440077·J Clin Psychopharmacol·2009
4-observational
Long-term effectiveness and safety of dexmethylphenidate extended-release capsules in adult ADHD.
PMID 19218542·J Atten Disord·2009
4-observational
Atomoxetine treatment in adults with attention-deficit/hyperactivity disorder and comorbid social anxiety disorder.
PMID 19194995·Depress Anxiety·2009
2-rct
Effect of lisdexamfetamine dimesylate on sleep in adults with attention-deficit/hyperactivity disorder.
PMID 19650932·Behav Brain Funct·2009
8-other
Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature.
PMID 18174822·J Am Acad Child Adolesc Psychiatry·2008
1-meta
Diagnosing and treating adult ADHD and comorbid conditions.
PMID 19200423·J Clin Psychiatry·2008
6-review
Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder.
PMID 19012818·J Clin Psychiatry·2008
4-observational
Best practices in adult ADHD: special considerations. Introduction.
PMID 18955947·CNS Spectr·2008
8-other
Best practices in adult ADHD. Neurobiology, pharmacology, and emerging treatment.
PMID 18849902·CNS Spectr·2008
8-other
Long-term, open-label safety and efficacy of atomoxetine in adults with ADHD: final report of a 4-year study.
PMID 18448861·J Atten Disord·2008
4-observational
The reliability and validity of self- and investigator ratings of ADHD in adults.
PMID 18025250·J Atten Disord·2008
2-rct
The impact, identification, and management of attention-deficit/hyperactivity disorder in adults. Introduction.
PMID 18163042·CNS Spectr·2007
8-other
Quality of life assessment in adult patients with attention-deficit/hyperactivity disorder treated with atomoxetine.
PMID 17110824·J Clin Psychopharmacol·2006
4-observational
Training raters to assess adult ADHD: reliability of ratings.
PMID 16009660·J Atten Disord·2005
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 355 W 52ND ST, 7TH FLOOR
NEW YORK, NY 10019 - Phone
- (646) 778-5555
Quick Facts
- NPI
- 1609898469
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 29
- Publications
- 20
Are you this provider?
Claim Your Profile